A groundbreaking study recently published in the prestigious journal Aging-US reveals key insights into the cross-species functionality of human telomerase, a vital enzyme responsible for the maintenance of chromosome ends. This research sheds light on the complex biology underlying telomere length regulation across different mammalian species and holds profound implications for the development of telomerase-based therapies aimed at combating aging and age-associated diseases.
Telomerase, a ribonucleoprotein enzyme complex, possesses the remarkable ability to add repetitive DNA sequences known as telomeres to chromosome termini, thereby preserving genomic stability. These telomeric regions are critical for protecting chromosomes from degradation and preventing the loss of genetic information during cell division. The catalytic subunit of this enzyme, termed TERT (telomerase reverse transcriptase), works in concert with an RNA component that provides the template for telomere elongation. However, understanding the extent to which human TERT can functionally operate within the cellular environments of other species has remained elusive until now.
The research team, led by Raúl Sánchez-Vázquez and Paula MartÃnez under the guidance of MarÃa A. Blasco at the Spanish National Cancer Centre (CNIO) in Madrid, embarked on an ambitious investigation. They introduced the human TERT gene into primary lung fibroblasts harvested from a diverse array of mammalian species commonly employed in preclinical models, including the cynomolgus monkey, pig, rabbit, rat, dog, and mouse. This cross-species experimental design enabled the assessment of human telomerase activity beyond solely human cells.
Initial in vitro analyses highlighted that recombinant human TERT was indeed capable of assembling enzymatically active telomerase complexes with the endogenous telomerase RNA components of multiple species—namely monkeys, pigs, rabbits, and rats. This biochemical compatibility suggested a degree of molecular conservation in the telomerase machinery across mammals. However, the study stepped beyond this reductionist biochemical perspective to evaluate functional outcomes within living cells, where regulatory networks and protein interactions dictate enzyme activity.
Strikingly, the researchers found that only cells derived from humans and non-human primates demonstrated sustained telomere elongation following infection with human TERT. In these cells, progressive extension of telomere length was measurable over time in culture, indicating effective integration and functional activity of the human telomerase enzyme. Conversely, cells from other examined species failed to maintain telomere length, despite some showing detectable telomerase activity initially. This discrepancy underscores the critical influence of complex species-specific factors that govern telomerase function in vivo, which are absent in simplified biochemical assays.
Further complicating the picture, notable deficiencies in supporting human TERT were observed within murine and canine fibroblasts. These cells not only lacked productive telomere extension but exhibited reduced viability and hallmarks of cellular stress upon expression of the human telomerase component. These findings suggest intrinsic incompatibilities that may stem from divergent regulatory protein networks, post-translational modifications, or chromatin environments that are incompatible with the human enzyme.
This study compellingly emphasizes the limitations inherent in applying common laboratory animal models such as mice and dogs for preclinical research targeting telomerase-based therapeutic strategies. Since telomerase biology is tightly controlled by a nexus of interacting factors that differ significantly across species, therapeutic approaches relying on human TERT function will likely require validation in models that recapitulate human telomerase dynamics more faithfully, particularly non-human primates.
The data affirm prior suspicions that biochemical reconstitution of telomerase activity in vitro does not guarantee successful functional integration in the cellular milieu. The recruitment of telomerase to telomeres, its stabilization, and regulation depend on accessory proteins and epigenetic factors that are species-specific, imposing barriers to cross-species enzyme functionality. Understanding these interdependencies provides crucial insights into the challenges faced when translating telomerase therapies from bench to bedside.
Given the pivotal role telomerase plays not only in normal cellular aging but also in pathological conditions such as cancer and telomere syndromes, elucidating species-specific functional compatibility is of paramount importance. The identification of non-human primate cells as uniquely permissive hosts for human TERT activity establishes them as the most appropriate in vivo platforms for preclinical studies aiming to evaluate telomerase-targeting interventions or regenerative medicine applications.
This work paves the way for refined animal modeling in aging research, offering a more faithful reproduction of human telomerase biology that is essential for assessing the efficacy and safety of potential drugs or gene therapies. By narrowing the translational gap, these findings enhance prospects for developing treatments that could delay cellular senescence, improve tissue regeneration, and ameliorate age-related diseases with telomere shortening components.
In conclusion, the investigation by the CNIO team represents a substantial advance in our understanding of telomerase biology across species barriers. The revelation that cellular context profoundly influences human TERT function redefines the parameters for selecting experimental models and prioritizes non-human primates in telomerase research. This nuanced perspective is critical for advancing therapeutic strategies that harness telomerase to combat aging and extend healthy lifespan.
Subject of Research: Cells
Article Title: Cross species activity of TERT human telomerase component
News Publication Date: 13-Apr-2026
Web References: https://doi.org/10.18632/aging.206372
Image Credits: © 2026 Raúl et al., distributed under the terms of the Creative Commons Attribution License (CC BY 4.0)
Keywords: telomerase, telomeres, molecular genetics, aging, chromosome stability, cross-species enzyme activity
Tags: age-associated diseases and telomerasechallenges of telomerase therapy developmentgenomic stability and aginghuman telomerase cross-species activitylimitations of animal models in aging researchribonucleoprotein enzyme in chromosome protectiontelomerase enzyme function in mammalstelomerase reverse transcriptase cross-species compatibilitytelomerase-based anti-aging treatmentstelomere length regulation mechanismstelomere maintenance in fibroblastsTERT gene expression in animal models
